Diabetes Treatments Market Report 2024 by Delvens offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The global Diabetes Treatments Market size was estimated at USD 82.7 billion in 2023 and is projected to reach USD 156.2 billion in 2030 at a CAGR of 5.0% during the forecast period 2024-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/diabetes-treatments-market
The global diabetes treatment market is a dynamic sector driven by the prevalence of diabetes mellitus, a metabolic disorder characterized by elevated blood sugar levels due to insufficient insulin production or improper cell response to insulin. This chronic condition affects millions worldwide and necessitates a comprehensive market for managing and treating its symptoms effectively.
North America to Dominate the Diabetes Treatments Market:
North America holds a substantial share of the global diabetes treatment market and is projected to grow at a promising compound annual growth rate (CAGR) in the coming years. Within North America, the United States leads in diabetes treatment. High insulin prices in the U.S., among the highest globally, have prompted patients to seek longer usage of insulin and explore more affordable options such as human insulin. This trend is expected to drive a decline in insulin prices in the near future, aiming to enhance affordability and accessibility of diabetes treatment options across the region.
The prominent players in the Diabetes Treatments Market are
· Roche Products Limited
· Johnson & Johnson Services, Inc.
· Sanofi-Deutschland GmbH
· Novo Nordisk A/S
· ARKRAY USA, Inc.
· Bayer AG
· Amylin Pharmaceuticals Inc.
· Abbott
· Medtronic Inc.
· Teva Pharmaceuticals Pvt Ltd.
· Home Diagnostics Inc.
· Novartis AG
· Eli Lilly and Company.
· Merck & Co., Inc
· AstraZeneca
· Boehringer Ingelheim International GmbH
· Takeda Pharmaceutical Company Limited and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/diabetes-treatments-market
Recent Developments:
In October 2022, Novo Nordisk intends to seek regulatory approval for once-weekly insulin icodec, positioning it as a potential leading treatment for type 2 diabetes. The pharmaceutical firm plans to submit applications in the US, EU, and China by mid-2023 following positive results from the ONWARDS 5 phase 3a trial comparing it to once-daily basal insulin over 52 weeks.
In May 2022, Novo Nordisk plans to invest around USD 98 million to modernize and expand its insulin production facility located in Kalundborg, Denmark.
The Diabetes Treatments Market is segmented into various segments such as Drug Class, Diabetes Type, Distribution Channel, and Region:
Based on Drug Class
· Insulin
· DPP-4 Inhibitors
· GLP-1 Receptor Agonists
· SGLT2 Inhibitors
Based on the Diabetes Type
· Type-1
· Type-2
Based on the Distribution Channel
· Online pharmacies
· Hospital Pharmacies
· Retail Pharmacies
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Access Full Report: https://www.delvens.com/report/diabetes-treatments-market
In addition to the market data for the Diabetes Treatments Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Frequently Asked Questions
· What are the years considered to study Diabetes Treatments Market intelligence report?
· What is the compound annual growth rate (CAGR) of the Diabetes Treatments Market?
· Which region holds the largest market share in Diabetes Treatments Market?
· Which region is the fastest growing in Diabetes Treatments Market?
· Who are the major players in Diabetes Treatments Market?
More Reports from Delvens:
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek